CD33, CD47, CAR T-cell and Novel Stem Cell Treatment Trends for 2017

CD33, CD47, CAR T-cell and Novel Stem Cell Treatment Trends for 2017

User Photo
ASHReport

4 years
1,165 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Jonathan Gerber, MD of Levine Cancer Institute, discusses advances in research and treatment trends for AML at the 58th ASH Annual Meeting in San Diego, CA.
Up Next Autoplay
>